Media, Video 22 Jun 2021 Video | Ticker News Interview – June 2021 Orthocell CEO and Managing Director, Paul Anderson, spoke with Ticker News about the positive findings from our CelGroâ„¢ clinical study. Orthocell
Media, Video 22 Jun 2021 Video | Proactive Investors – June 2021 Orthocell CEO and Managing Director Paul Anderson discusses with Proactive positive nerve regeneration results one year on from a study… Orthocell
Video 21 Jun 2021 Orthocell (ASX:OCC) demonstrates potential to return function to paralysed limbs Orthocell has been featured in The Market Herald, following the announcement of clinical data from the CelGro nerve regeneration trial… Orthocell
Media 16 Jun 2021 Orthocell (ASX:OCC) secures Chinese and NZ patents Orthocell has been featured in The Market Herald, following our announcement of patents granted in China and New Zealand for… Orthocell
Media, Video 27 May 2021 Video | Proactive Investors – May 2021 Orthocell CEO and Managing Director Paul Anderson speaks to Proactive following the announcement newly granted patents for its CelGroâ„¢ collagen… Orthocell
Media 26 May 2021 Orthocell (ASX:OCC) granted new patents for ACL repair treatment Orthocell has been featured in The Market Herald, following our announcement of granted patents in China and Hong Kong for… Orthocell
Media 15 Feb 2021 Orthocell (ASX:OCC) receives new U.S. patent for CelGro Orthocell has been featured in The Market Herald, following the announcement of a newly granted U.S. divisional patent for CelGro.… Orthocell
Media 14 Jan 2021 Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device BioWorld has reported on Orthocell's rising share price, following the U.S. approval for our collagen medical device for dental guided… Orthocell
Media 09 Jan 2021 UWA invention to speed up healing in dental patients Orthocell's Striate+â„¢ has been featured in Bite Magazine, highlighting its effectiveness for dental bone defect repair and tissue augmentation around… Orthocell
Video 06 Jan 2021 Australia’s TGA approves Orthocell’s Celgroâ„¢ regenerative collagen medical device Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgroâ„¢ collagen… Orthocell
